EBV BCL-2 homologue BHRF1 drives chemoresistance and lymphomagenesis by inhibiting multiple cellular pro-apoptotic proteins

Leah Fitzsimmons, Rachael Cartlidge, C. Chang, Nenad Sejic, L. C. A. Galbraith, C. D. Suraweera, Deborah Croom-Carter, G. Dewson, Rosemary Tierney, Andrew Bell, Claire Shannon-Lowe, Marco Herold, Alan Rickinson, P. M. Colman, D. C. S. Huang, Andreas Strasser, Mark Kvansakul, Martin Rowe, Gemma L. Kelly

Research output: Contribution to journalArticlepeer-review

8 Citations (Scopus)

Fingerprint

Dive into the research topics of 'EBV BCL-2 homologue BHRF1 drives chemoresistance and lymphomagenesis by inhibiting multiple cellular pro-apoptotic proteins'. Together they form a unique fingerprint.

Medicine & Life Sciences